Steminent Biotherapeutics, Inc (TPEX:7729)

Market Cap	1.22B
Revenue	n/a
Net Income	n/a
Shares Out	56.11M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,032
Average Volume	75,205
Open	21.70
Previous Close	21.70
Day's Range	21.20 - 22.60
52-Week Range	15.25 - 36.65
Beta	n/a
RSI	46.16
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics, Inc., a stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. The company focuses on Stemchymal portfolio of cell therapy research and development programs based on allogeneic stem cells that target neurodegenerative and other degenerative diseases. Its product pipeline includes various pre-clinical and clinical stage therapeutic programs for the treatment of spinocerebellar ataxia (PolyQ SCA), osteoarth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729